Daily consumption of cranberry extract can significantly reduce the frequency of recurrent urinary tract infections (R-UTIs) without the adverse effects endured after treatment with antibiotics, according to a recent study.
A probiotic and cranberry supplement can significantly reduce recurrent urinary tract infections (rUTIs) in premenopausal women, as well as shorten the duration of infections and reduce the need for antibiotic treatment, a study has shown.
The cranberry industry and academics have rubbished a cranberry-UTI study and accompanying commentary published in JAMA in the past week, saying the research is “misleading” and “suffering from fatal flaws.”
The elderberry may play a larger role than previously thought in counteracting the decline in neuronal and cognitive functions, particularly in Alzheimer’s disease, according to research presented at the 10th World congress on Polyphenol Applications...
Delving deeper into a popular remedy that has lacked solid scientific backing, a new placebo-controlled study found that cranberry juice consumption lowered clinical urinary tract infection (UTI) episodes in women with a recent history of UTIs.
A combination of proanthocyanidins (c-PAC) derived from cranberries with select probiotic strains may reduce the invasiveness of Escherichia coli, and help protect against urinary tract infections (UTIs).
The European Commission (EC) has issued a draft that seeks to revoke the medical device status of proanthocyanidin (PAC)-based cranberry products for treatment and prevention of Urinary Tract Infections (UTI).
Naturex’s launch of a new cranberry extract sees the company moving beyond proanthocyanidins (PACs) as a marker of efficacy towards anti-adhesion activity (AAA), something it sees as a more relevant biological marker of benefits to urinary tract health.
New Jersey supplier Pharmachem says a European Food Safety Authority (EFSA) rejection of its ‘CranMax’ cranberry ingredient’s ability to prevent urinary tract infection (UTI) in women won’t change its European business plans.
Naturex and Pharmachem are the latest cranberry players to be rebuffed by the EU’s central science agency. In the first, it this week failed French botanical giant Naturex's urinary tract infection (UTI) dossier containing a key study it said, “showed...
Non-fermented carbohydrates can deliver tooth health benefits but there is not enough data to show cranberry can benefit urinary tract infections, the European Food Safety Authority (EFSA) has found in a new series of health claim opinions.
New research that sheds light on the biological mechanisms behind cranberry's protective properties for recurrent urinary tract infections (UTI) may also point towards a potential role for cranberry derivatives in medical devices.
Inappropriate products and trial design caused the Cochrane Collaboration to alter its position about the urinary tract infection (UTI)-reducing benefits of cranberry juice, the owner of a French cranberry supplements company has said.
The link between cranberries and urinary tract health is well established, said researchers in the field who disputed the results of a recent Cochrane review that questioned the berry’s benefits in fighting urinary tract infections (UTIs).
Cranberry juice does not appear to have a significant benefit in preventing urinary tract infections and may be 'unacceptable' to consume in the long term, according to the findings of a new systematic review by the Cochrane Collaboration.
French botanicals and ingredients supplier, Nexira, has made good its promise to expand its portfolio and operations by acquiring fellow French firm, Tournay Biotechnologies, for an undisclosed cash sum.
Gunter Haesaerts, the man who in 2004 convinced French authorities that cranberries could be beneficial for the urinary tract and won an associated health claim, has submitted a proprietary claim to the EU’s food safety agency via his high-dose cranberry...
With a recently awarded medical devices urinary tract infection (UTI) claim in the bag, Dutch start-up Medical Brands booked a late booth at Vitafoods Europe, keen to show off its achievement to a food sector that has been denied EU health claims.
€3 million and seven years of research and development work have paid off for Medical Brands which has won the right to make medical urinary tract infection (UTI) claims in the EU and beyond with its cranberry partner, Decas Botanical Synergies (DBS).
High quality chromium picolinate, the blood glucose controlling mineral form last year approved for use in foods in the European Union by the European Food Safety Authority (EFSA), is benefitting from the approval that backed high quality forms of the...
French cranberry firm Pharmatoka says the European Food Safety Authority (EFSA) failed to assess its submitted urinary tract infection (UTI) health claim wording, which was the very same as that approved by the French Food Agency (ANSES) in 2004.
The cranberry industry, divided over differing methods of measuring the active proanthocyanidins (PACs) content of the berries, are offering differing interpretations of new advice from the French food agency (ANSES).
The long-standing dispute within the cranberry industry about the most appropriate way to measure the urinary tract infection (UTI)-battling berry’s active constituents was resolved in France recently when a government body backed a version of the DMAC...
The French authorities have moved to settle the controversy over conflicting methodologies for quantifying PAC levels in cranberry extracts, determining that the new BL-DMAC method should be used by all companies using the French health claim.
A combination of cranberry powder and probiotic bacteria for the management of urinary tract infections (UTI) has been released by Lallemand Health Ingredients and Institut Rosell-Lallemand with guaranteed extended shelf life.